Biosimilars, Year One: FDA Estimates 2 Applications, 1,720 Hours Of Work
Executive Summary
The agency’s expectation is that there will be a limited number of biosimilar applications, but the applicants will need as much time as traditional BLA sponsors to prepare their submissions.